{"id":"NCT00033631","sponsor":"Radiation Therapy Oncology Group","briefTitle":"Radiation Therapy in Treating Patients With Stage II Prostate Cancer","officialTitle":"A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-03","primaryCompletion":"2014-04","completion":"2022-12-22","firstPosted":"2003-01-27","resultsPosted":"2017-02-08","lastUpdate":"2023-01-18"},"enrollment":1534,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer"],"interventions":[{"type":"RADIATION","name":"70.2 Gy 3D-CRT/IMRT","otherNames":["3D conformal radiation therapy","intensity modulated radiation therapy"]},{"type":"RADIATION","name":"79.2 Gy 3D-CRT/IMRT","otherNames":["3D conformal radiation therapy","intensity modulated radiation therapy"]}],"arms":[{"label":"70.2 Gy","type":"ACTIVE_COMPARATOR"},{"label":"79.2 Gy","type":"EXPERIMENTAL"}],"summary":"RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. It is not yet known which dose of radiation therapy is more effective in treating stage II prostate cancer.\n\nPURPOSE: Randomized phase III trial to compare the effectiveness of two different doses of specialized radiation therapy in treating patients who have stage II prostate cancer.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"From randomization to date of failure (death) or last follow-up. Analysis occurs after all patients have been potentially followed for 8 years.","effectByArm":[{"arm":"70.2 Gy","deltaMin":88.5,"sd":null},{"arm":"79.2 Gy","deltaMin":88.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.98"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":86,"countries":["United States","Canada"]},"refs":{"pmids":["18674684","17825932","38320143","37751207","37137444","36884035","29543933"],"seeAlso":["https://nctn-data-archive.nci.nih.gov/"]},"adverseEventsSummary":{"seriousAny":{"events":30,"n":744},"commonTop":["Impotence","Urinary frequency","Urinary incontinence","Late RT Toxicity: Bladder/Other GU: NOS","Late RT Toxicity: Bowel : NOS"]}}